In order to better evaluate the prognosis of patients with CRC, the independent prognostic factors of M stage, TNM stage, and serum IGFBP-1 were used to establish a nomogram to forecast 1-, 3- and 5-years OS probability prediction (Fig. 5). This evidence concerns the gene IGFBP1 and colorectal carcinoma.